VTGN

VistaGen Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
VistaGen Therapeutics Inc VTGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.54 19:00:00
Open Price Low Price High Price Close Price Prev Close
1.54
more quote information »

Recent News

Date Time Source Heading
1/20/202211:08IHNWFeaturedCOINANALYST CORP. ANNOUNCES PROPOSED ACQUISITION OF ROCKSTOCK EQUITIES INC.
1/20/20228:00IHNWFeatured121 Mining Investment coming to Las Vegas - register for your free investor pass today
1/20/20227:30IHNWFeaturedAmerican Green, Inc.™ (OTC:ERBB) Cannabis Grow Operations at "Sweet Virginia" and Newly Under Construction "Cypress Chill" Pave Way for Increased Revenue and More Expansion in 2022
1/12/202217:22EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202216:26EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202216:20EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202216:19EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202109:57EDGARConfidential Treatment Order (ct Order)
11/16/202108:30GLOBEVistaGen Therapeutics to Present at the Jefferies London..
11/10/202116:46EDGARCurrent Report Filing (8-k)
11/10/202116:28SEEKVistaGen Therapeutics EPS misses by $0.01, beats on revenue
11/10/202116:20GLOBEVistaGen Therapeutics Reports Fiscal Year 2022 Second..
11/10/202116:19EDGARQuarterly Report (10-q)
11/09/202117:35SEEKVistaGen Therapeutics Q2 2022 Earnings Preview
11/04/202108:00GLOBEVistaGen Therapeutics to Report Fiscal Year 2022 Second..
10/15/202106:33EDGARCurrent Report Filing (8-k)
10/14/202108:00GLOBEVistaGen Therapeutics Expands Clinical Development of PH94B..
10/05/202117:23EDGARCurrent Report Filing (8-k)
10/05/202108:00GLOBEVistaGen Therapeutics Reports New Preclinical Mechanism of..
9/24/202116:16EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/13/202106:00GLOBEVistaGen Therapeutics Further Advances PALISADE Phase 3..
9/08/202118:58EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202108:00GLOBEVistaGen Therapeutics to Participate in Baird’s 2021 Global..
9/03/202116:19EDGARStatement of Changes in Beneficial Ownership (4)
8/18/202118:21EDGARStatement of Changes in Beneficial Ownership (4)
8/12/202116:53EDGARCurrent Report Filing (8-k)
8/12/202116:25GLOBEVistaGen Therapeutics Reports Fiscal Year 2022 First Quarter..
8/09/202116:05GLOBEVistaGen Therapeutics to Report Fiscal Year 2022 First..
8/02/202108:00GLOBEVistaGen Therapeutics to Participate in Canaccord Genuity..
7/29/202117:14EDGARProxy Statement (definitive) (def 14a)
7/22/202116:12EDGARStatement of Changes in Beneficial Ownership (4)
7/22/202116:07EDGARCurrent Report Filing (8-k)
7/22/202108:07SEEKVistaGen Therapeutics adds Maggie FitzPatrick to its board..
7/22/202108:00GLOBEVistaGen Therapeutics Announces Appointment of Maggie..
7/21/202116:06EDGARCurrent Report Filing (8-k)
7/09/202108:30GLOBEVistaGen Therapeutics to Participate in William Blair..
7/09/202106:07TRMNWhat Do VistaGen’s Newly Added Risk Factors Mean for..
7/08/202116:16EDGARCurrent Report Filing (8-k)
7/07/202116:49EDGARStatement of Changes in Beneficial Ownership (4)
7/07/202116:47EDGARInitial Statement of Beneficial Ownership (3)
7/07/202108:38SEEKVistaGen appoints Mary Rotunno to board of directors
7/07/202108:30GLOBEVistaGen Therapeutics Announces Appointment of Mary L...
7/02/202116:12EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202116:11EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202116:11EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202116:11EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202116:17SEEKVistaGen Therapeutics EPS misses by $0.27, beats on revenue
6/29/202116:15GLOBEVistaGen Therapeutics Reports Fiscal Year 2021 Financial..
6/29/202116:09EDGARCurrent Report Filing (8-k)
6/29/202116:07EDGARAnnual Report (10-k)
6/25/202108:00GLOBEVistaGen Therapeutics to Report 2021 Fiscal Year End..
6/16/202108:27SEEKVistaGen Therapeutics added to Russell 2000 Index
6/16/202108:00GLOBEVistaGen Therapeutics Set to Join the Russell 2000® Index
See more news about this stock »


Your Recent History
NASDAQ
VTGN
VistaGen T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.